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Objective: To observe the correlation between the condition of patients with acute ce-
rebral infarction and serum b2-microglobulin (b2-MG) levels.
Methods: Patients with acute cerebral infarction and healthy physical examinees
selected for the prospective study were included into the cerebral infarction group and
control group, respectively. Clinical data were collected and the patients' condition were
evaluated, and then the contents of the b2-MG, high sensitivity C reactive protein
(hsCRP), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-a (TNF-a),
intercellular cell adhesion molecule-1 (ICAM-1) and soluble CD40 Ligand (sCD40L) in
serum were tested.
Results: The contents of serum b2-MG, hsCRP, IL-6, IL-8, TNF-a, ICAM-1, sCD40L
in patients with acute cerebral infarction were obviously higher than those in cases of the
control group. The severer the condition of the disease was, the higher contents of serum
b2-MG, hsCRP, IL-6, IL-8, TNF-a, ICAM-1 and sCD40L became. The greater the
volume of cerebral infarction was, the higher the contents of serum b2-MG, hsCRP, IL-6,
IL-8, TNF-a, ICAM-1 and sCD40L were. The content of serum b2-MG was positively
associated with the contents of hsCRP, IL-6, IL-8, TNF-a, ICAM-1 and sCD40L.
Conclusions: The level of serum b2-MG was abnormally elevated in the patients with
acute cerebral infarction. The level of serum b2-MG can evaluate the severity of disease,
infarction size and the degree of inﬂammation reaction in patients with acute cerebral
infarction.1. Introduction
Acute cerebral infarction is a common cerebrovascular dis-
ease with high disability rates and fatality rates, which is an
important and difﬁcult point in clinical treatment[1,2]. The
pathophysiological process after the occurrence of the
ischemic infarction in brain tissue is very complicated and is
not yet entirely clear. Inﬂammation reaction, cell apoptosis,
and oxidative stress injury are proved to be closely related to
cerebral infarction[3–5]. The inﬂammation reaction, which isabnormally activated by the infarctions focus, is the key part
of causing the injury of neural function and the development
of the cerebral infarction. Various inﬂammatory factors [C-
reactive protein (CRP), tumor necrosis factor-a (TNF-a),
interleukin-6 (IL-6)] and adhesion molecules intercellular cell
adhesion molecule-1 (ICAM-1), vascular cell adhesion
molecule-1, soluble CD40 ligand (sCD40L)] also participate in
this process[6–8]. The contents of inﬂammatory factors and
adhesion molecules can reﬂect the severity of cerebral
infarction in some extent, however, due to the complex
process of the inﬂammation reaction and the involvement of
multiple links, and the changed cytokines in serum of different
patients with cerebral infarction might have differences, which
cause the condition of disease cannot be accurately evaluated
through the detection of single cytokine.
In recent years, clinical scholars have devoted to search for a
serum index that can accurately evaluate the patients' condition
of cerebral infarction. b2-microglobulin (b2-MG) is the micro-
molecular protein separated from tubular proteinuria byer the CC BY-NC-ND license (http://
Table 1
Clinical data of patients in the two groups.
Terms Cerebral infarction
group (n = 62)
Control group
(n = 65)
P
Gender (male/
female)
38/24 40/25 > 0.05
Age (year) 54.10 ± 9.80 55.70 ± 8.40 > 0.05
BMI (kg/m2) 22.92 ± 2.83 22.53 ± 2.75 > 0.05
Hypertension 35 (56.45%) 9 (13.85%) < 0.05
Diabetes 18 (29.03%) 4 (6.15%) < 0.05
Smoke 26 (41.94%) 8 (12.31%) > 0.05
Triglyceride (mmol/
L)
1.71 ± 0.20 1.78 ± 0.18 > 0.05
Cholesteryl ester
(mmol/L)
4.62 ± 0.51 4.49 ± 0.64 > 0.05
Blood urea nitrogen
(mmol/L)
5.29 ± 0.55 5.44 ± 0.62 > 0.05
Serum creatinine 68.12 ± 7.96 66.38 ± 7.57 > 0.05
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distributes in almost all human cells except erythrocytes and
placenta trophocytes, and it was mainly composed and
secreted by lymphocytes, neutrophile granulocytes,
mononuclear macrophages and mesenchymal cells. The
synthetic rate and clearance rate of in vivo b2-MG maintain a
relative balance. The content of b2-MG in serum will be
abnormally elevated when b2-MG is over-compounded or the
elimination becomes difﬁcult. The numbers of lymphocytes,
neutrophile granulocytes and mononuclear macrophages will be
signiﬁcantly increased when body's inﬂammatory reaction was
activated, which causes the increase of the synthesis of b2-
MG[10,11]. As previously mentioned, the activation of
inﬂammatory reaction is an important link in the development
of the acute cerebral infarction. Therefore, we speculated that
in the process of the occurrence of acute cerebral infarction,
the activation of the inﬂammatory reaction can increase the
numbers of multiple inﬂammatory cells, and then increase the
synthesis of b2-MG. The severity condition of patients with
cerebral infarction can be evaluated by detecting the content of
serum b2-MG. In order to verify this speculation, we analyzed
the correlation between the condition of patients with acute ce-
rebral infarction and serum b2-MG levels.
2. Materials and methods
2.1. Group cases
A prospective study was carried out after setting the inclusion
criteria and exclusion criteria, including the cerebral infarction
group and control group. The study has been approved by the
Hospital Ethics Committee, and patients in groups signed the
informed consent. Patient with acute cerebral infarction was
selected as research objects in the cerebral infarction group. The
inclusion criteria required patients to meet the academic stan-
dards by The Chinese Neuroscience Society and The Chinese
Neurosurgical Society[12], and patients suffering from cerebral
infarction for the ﬁrst time and admitting to hospital within
24 h proved to have infarction by emergent CT after
admission. Patients combined with severe heart and lung
diseases or hepatic and renal dysfunction and patients with the
history of an infection in recent 1 month were excluded.
Research objects in the control group were all selected from
the physical examination center of our hospital. Their gender,
age and body mass index (BIM) matched with those of
patients in the cerebral infarction group, and patients with
cerebrovascular disease and liver and kidney dysfunction were
excluded after physical examination.
2.2. Study methods
Gender, age, height, weight, cases of hypertension, diabetes,
hyperlipidemia and smoking history of patients of the two groups
were collected in accordance with the case data of patients in the
cerebral infarction group and the medical examination reports of
healthy objects in the control group. Patients with cerebral
infarction received scores of National Institutes of Health Stroke
Scale (NIHSS) after admission. The scores less than 7 were mild
cases, 7–15 were moderate cases, more than 15 were serious
cases. The volume of cerebral infarction was calculated accord-
ing to Pullicino formula after conducting emergency CT.Cerebral infarction volume = length (cm) × width (cm) × scanned
positive layers/2.
The hematoma volume < 4 cm3 was considered as small-size
infarction; 4–10 cm3 was medium-size infarction; and > 10 cm3
was large-size infarction. On admission, 10 mL peripheral venous
blood of patients with cerebral infarction was collected immedi-
ately, and also 10mLperipheral venous blood of healthy people in
the control group was collected at physical examination. Blood
were placed at room temperature for 10–15 min, and centrifuged
at 3 000 r/min for 10 min to collect the upper serum and the
contents of b2-MG, high sensitivity C reactive protein (hsCRP),
IL-6, IL-8, TNF-a, ICAM-1, sCD40L were tested by ELISA.
2.3. Statistical analysis
Data were analyzed by SPSS version 19.0. Measurement data
were all expressed with mean ± SD. Data between two groups
were analyzed by t-test, and data among three groups were
analyzed by ANOVA. Enumeration data were expressed by
frequencies and analyzed by Chi-square test. Correlations be-
tween two variables were tested by Pearson's correlation anal-
ysis. Differences were statistically signiﬁcant (P < 0.05).
3. Results
3.1. General clinical data of objects in the two groups
Among 62 cases in the cerebral infarction group, 38 of them
were males and 24 were females with ages ranging from
(54.1 ± 9.8) years and the BMI of (22.92 ± 2.83) kg/m2. There
were 35 cases of hypertension, 18 cases of diabetes and 26 cases
of smoking history. The concent of triglyceride was
(1.71 ± 0.20) mmol/L, cholesteryl ester was (4.62 ± 0.51) mmol/
L, urea nitrogen was (5.29 ± 0.55) mmol/L, and serum creatinine
was (68.12 ± 7.96) mmol/L. Among 65 cases in the control
group, 40 cases of them were males and 25 cases were females
with ages ranging from (55.7 ± 8.4) years and the BMI of
(22.53 ± 2.75) kg/m2. There were 9 cases of hypertension, 4
cases of diabetes, 8 cases of smoking history, and the contents of
triglyceride, cholesteryl ester, blood urea nitrogen and serum
creatinine were (1.78 ± 0.18) mmol/L, (4.49 ± 0.64) mmol/L,
(5.44 ± 0.62) mmol/L and (66.38 ± 7.57) mmol/L, respectively
(Table 1).(mmol/L)
Table 3
Contents of serum b2-MG, inﬂammatory factors and adhesion molecules
in patients with different severity of cerebral infarction.
Terms Mild cerebral
infarction
Moderate
cerebral
infarction
Severe cerebral
infarction
P
b2-MG
(mg/L)
1.77 ± 0.20 2.51 ± 0.30 3.98 ± 0.44 < 0.05
hsCRP
(mg/L)
10.14 ± 1.14 17.22 ± 2.33 29.22 ± 3.47 < 0.05
IL-6 (ng/
L)
15.04 ± 1.78 23.41 ± 2.97 34.01 ± 3.33 < 0.05
IL-8 (mg/
L)
1.78 ± 0.22 2.97 ± 0.35 5.91 ± 0.68 < 0.05
TNF-a
(mg/L)
43.14 ± 5.89 72.33 ± 9.41 101.33 ± 16.22 < 0.05
ICAM-1
(mg/L)
302.10 ± 34.80 401.20 ± 50.20 572.30 ± 68.70 < 0.05
sCD40L
(mg/L)
1.77 ± 0.19 2.59 ± 0.29 4.47 ± 0.58 < 0.05
Table 4
Contents of serum b2-MG, inﬂammatory factors and adhesion molecules
in patients with different volume of cerebral infarction.
Terms Small volume
of cerebral
infarction
Medium volume
of cerebral
infarction
Large volume
of cerebral
infarction
P
b2-MG
(mg/L)
1.69 ± 0.19 2.65 ± 0.32 3.85 ± 0.41 < 0.05
hsCRP
(mg/L)
9.48 ± 1.14 16.87 ± 2.19 30.49 ± 3.68 < 0.05
IL-6 (ng/
L)
14.27 ± 1.95 22.13 ± 2.62 33.28 ± 3.96 < 0.05
IL-8 (mg/
L)
1.66 ± 0.22 3.15 ± 0.39 5.57 ± 0.61 < 0.05
TNF-a
(mg/L)
40.39 ± 5.38 69.48 ± 9.68 95.65 ± 14.59 < 0.05
ICAM-1
(mg/L)
289.50 ± 32.60 389.40 ± 47.90 597.70 ± 71.40 < 0.05
sCD40L
(mg/L)
1.89 ± 0.22 2.64 ± 0.31 4.18 ± 0.55 < 0.05
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and adhesion molecules of patients in the two groups
The contents of b2-MG [(2.91 ± 0.34) vs. (1.28 ± 0.14) mg/
L], hsCRP [(19.34 ± 2.41) vs. (2.96 ± 0.33) mg/L], IL-6
[(24.91 ± 2.63) vs. (9.84 ± 1.06) ng/L], IL-8 [(3.85 ± 0.41) vs.
(0.78 ± 0.12) mg/L], TNF-a [(75.71 ± 12.48) vs. (20.44 ± 4.96)
mg/L], ICAM-1 [(412.50 ± 56.40) vs. (147.60 ± 18.50) mg/L],
sCD40L [(2.85 ± 0.35) vs. (1.14 ± 0.13) mg/L] in serum of the
patients with acute cerebral infarction were obviously higher
than those in control group (Table 2).
3.3. Contents of serum b2-MG, inﬂammatory factors
and adhesion molecules in patients with different
severity of cerebral infarction
The contents of serum b2-MG, hsCRP, IL-6, IL-8, TNF-a,
ICAM-1 and sCD40L in patients with different severity of ce-
rebral infarction were different. The severer condition of cerebral
infarction led to the higher contents of serum b2-MG
[(1.77 ± 0.20) vs. (2.51 ± 0.30 vs. (3.98 ± 0.44) mg/L],
hsCRP [(10.14 ± 1.14) vs. (17.22 ± 2.33) vs. (29.22 ± 3.47) mg/
L], IL-6 [(15.04 ± 1.78) vs. (23.41 ± 2.97) vs. (34.01 ± 3.33) ng/
L], IL-8 [(1.78 ± 0.22) vs. (2.97 ± 0.35) vs. (5.91 ± 0.68) mg/L],
TNF-a [(43.14 ± 5.89) vs. (72.33 ± 9.41) vs. (101.33 ± 16.22)
mg/L], ICAM-1 [(302.10 ± 34.80) vs. (401.20 ± 50.20) vs.
(572.30 ± 68.70) mg/L] and sCD40L [(1.77 ± 0.19) vs.
(2.59 ± 0.29) vs. (4.47 ± 0.58) mg/L] (Table 3).
3.4. Contents of serum b2-MG, inﬂammatory factors
and adhesion molecules in patients with different volume
of cerebral infarction
There were differences among the contents of serum b2-MG,
hsCRP, IL-6, IL-8, TNF-a, ICAM-1, sCD40L in patients with
different volume of cerebral infarction. The greater volume of
cerebral infarction resulted in the higher contents of serum b2-
MG [(1.69 ± 0.19) vs. (2.65 ± 0.32) vs. (3.85 ± 0.41) mg/L],
hsCRP [(9.48 ± 1.14) vs. (16.87 ± 2.19) vs. (30.49 ± 3.68) mg/
L], IL-6 [(14.27 ± 1.95) vs.(22.13 ± 2.62) vs. (30.49 ± 3.68) ng/
L], IL-8 [(1.66 ± 0.22) vs. (3.15 ± 0.39) vs. (5.57 ± 0.61) mg/L],
TNF-a [(40.39 ± 5.38) vs. (69.48 ± 9.68) vs. (95.65 ± 14.59) mg/Table 2
Contents of serum b2-MG, inﬂammatory factors and adhesion molecules
of patients in the two groups.
Terms Cerebral infarction group
(n = 62)
Control group
(n = 65)
P
b2-MG
(mg/L)
2.91 ± 0.34 1.28 ± 0.14 < 0.05
hsCRP (mg/
L)
19.34 ± 2.41 2.96 ± 0.33 < 0.05
IL-6 (ng/L) 24.91 ± 2.63 9.84 ± 1.06 < 0.05
IL-8 (mg/L) 3.85 ± 0.41 0.78 ± 0.12 < 0.05
TNF-a (mg/
L)
75.71 ± 12.48 20.44 ± 4.96 < 0.05
ICAM-1
(mg/L)
412.50 ± 56.40 147.60 ± 18.50 < 0.05
sCD40L
(mg/L)
2.85 ± 0.35 1.14 ± 0.13 < 0.05L], ICAM-1 [(289.50 ± 32.60) vs. (389.40 ± 47.90) vs.
(597.70 ± 71.40) mg/L] and sCD40L [(1.89 ± 0.22) vs.
(2.64 ± 0.31) vs. (4.18 ± 0.55) mg/L] (Table 4).4. Discussion
Cerebral apoplexy is one of the three fatal diseases world-
wide and also a common cause for long-term disability[13].
Cerebral apoplexy was divided into cerebral arterial
thrombosis and hemorrhagic apoplexy, in which cerebral
arterial thrombosis has a relatively high morbidity rate
accounting for about 87% of cerebral apoplexy[14,15]. Cerebral
arterial thrombosis, also known as cerebral infarction, is
caused by hypoxia-ischemia brain injury. The physiopatho-
logic mechanism involved in this damage process is very com-
plex. Multiple inﬂammatory factors, adhesion molecules
apoptotic molecules and oxidative stress molecules are all
related to the ischemic injury of the brain tissue[16–19].
Inﬂammatory responses are considered as important changes
of cerebral infarction throughout various pathologic stages.
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large number of inﬂammatory factors leading to brain tissue
damage by microthrombus embolism, oxygen radical
generation and endothelial cell damage, etc.[20,21]. The massive
gathering of inﬂammatory cells will synthesize and secrete
multiple inﬂammatory factors and chemotactic factor.
Although the changes of the related cytokine contents in
serum can provide values for disease assessment[22,23], the
detection of single cytokine content in serum could not
accurately evaluate the condition of disease because the
changed cytokines in serum of different patients with cerebral
infarction might be different.
In this study, b2-MG was selected to evaluate the disease
severity for patients with acute cerebral infarction. At ﬁrst, by
analyzing the differences of contents of serum b2-MG between
patients with acute cerebral infarction and healthy objects, we
found that the content of serum b2-MG in patients with acute
cerebral infarction was signiﬁcantly elevated. Lymphocytes,
neutrophile granulocytes, mononuclear macrophages and
mesenchymal cells in bodies are the main source for b2-
MG[24,25], while in the development process of acute cerebral
infarction, the aggregation of multiple inﬂammatory cells in
lesions can not only synthesize and secrete various
inﬂammatory factors, and chemotactic factors, but also
generate a lot of b2-MG. In addition, atherosclerosis is an
important pathological character in patients with cerebral
infarction. A large number of lymphocytes existing in the
atheromatous plaque can induce the change of plaque charac-
teristic and accelerate the progress of cerebral infarction. Ac-
cording to the analysis of the content of serum b2-MG, the
severer cerebral infarction is, the greater infarct volume and the
higher content of serum b2-MG will be. It can be concluded that
the increase of the content of b2-MG is related to the occurrence
and development of acute cerebral infarction and disease
development. Combining the source of in vivo b2-MG, inﬂam-
matory reaction is the main approach for b2-MG to participate
cerebral infarction.
Inﬂammatory factors are the most important cell factors for
mediating inﬂammatory reactions. HsCRP is a acute phase
protein, which increases rapidly after the occurrences of various
acute inﬂammatory reactions, tissue damages, myocardial
infarction, cerebral infarction, etc. Its content is positively
correlated to the degree of inﬂammatory reaction. The mecha-
nism of action of hsCRP are to activate the complement, induce
the gathering of mononuclear macrophage and enhance vascular
permeability and secretion of adhesion molecule, etc.[26]. TNF-a
is a polypeptide cytokines secreted by activated mononuclear
macrophage, which can directly damage the blood brain
barrier, injury endothelial cells, increase the adhesion of
inﬂammatory cells for vascular endothelial cell[27]. IL-6 and
IL-8 are cytokines with multiple immune modulating functions
and stronger chemotactic effect, which can increase the gath-
ering of neutrophile granulocytes in the inﬂammatory site,
induce the occurrence of degranulation, generate reactive oxy-
gen metabolites and damage histocytes[28,29]. In the analysis of
the content of inﬂammatory factors in serum, we found that
the contents of serum hsCRP, IL-6, IL-8 and TNF-a increased
obviously, and showed a positive correlation with the content of
serum b2-MG, which suggested that the variation trend of the
content of serum b2-MG was consistent with the changes of
inﬂammatory factors contents, so that the degree of inﬂamma-
tory reaction can be assessed by detecting the content of b2-MG.In the progress of the activation and development of in-
ﬂammatory reactions, apart from the inﬂammatory factors
mentioned above, various adhesion molecules also play an
important role in regulation. ICAM-1 is a glycoprotein on the
membrane surface mediating cells and intercellular adhesion,
cells and extracellular adhesion mechanisms. In the pathological
process of cerebral infarction, the combination of ICAM-1 and
ligand CD11a/CD18 can mediate the adhesion of hemameba in
peripheral blood and vascular endothelial cells, penetrate
vascular wall and inﬁltrate in the infarct area, and then aggravate
inﬂammatory reaction of brain tissue. CD40L is a trans-
membrane glycoprotein of the complementary pairing with
CD40. The combination of two substances can recruit various
inﬂammatory cells and increase the secretion of inﬂammatory
factors, tissue factors, and matrix metalloproteinase[30]. In the
analysis of the content of adhesion molecules in serum, we
found that the contents of serum ICAM-1 and sCD40L
increased signiﬁcantly, and showed a positive correlation with
the content of serum b2-MG, which indicated that the variation
trend of the content of serum b2-MG was consistent with the
contents of inﬂammatory factors. Thus, it was further veriﬁed
that the detection of the content of b2-MG can assess the degree
of the inﬂammatory reaction.
In conclusion, the level of serum b2-MG was elevated
abnormally in patients with acute cerebral infarction. The serum
b2-MG level can assess the severity, infarction size and degree
of inﬂammatory reaction in patients with acute cerebral
infarction.Conﬂict of interest statement
The authors report no conﬂict of interest.
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